These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The beta-adrenergic receptor adenylate cyclase complex of Rauscher murine erythroleukemia cells and its response to erythropoietin-induced differentiation. Sytkowski AJ; Kessler CJ Blood; 1984 Jul; 64(1):84-90. PubMed ID: 6329380 [TBL] [Abstract][Full Text] [Related]
3. Erythroid differentiation of clonal Rauscher erythroleukemia cells in response to erythropoietin or dimethyl sulfoxide. Sytkowski AJ; Salvado AJ; Smith GM; McIntyre CJ; deBoth NJ Science; 1980 Oct; 210(4465):74-6. PubMed ID: 6932101 [TBL] [Abstract][Full Text] [Related]
4. The biochemistry of erythropoietin: an approach to its mode of action. Sytkowski AJ; McIntyre CJ; Perrine SP; Salvado AJ Exp Hematol; 1980; 8 Suppl 8():52-64. PubMed ID: 6962071 [TBL] [Abstract][Full Text] [Related]
5. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
6. Dimethyl sulfoxide amplification of the erythropoietin response: clues to the signal transduction pathway. Chern YE; Yonekura S; Sytkowski AJ Prog Clin Biol Res; 1990; 352():161-7. PubMed ID: 2169627 [No Abstract] [Full Text] [Related]
7. Erythroid differentiation and the cell cycle: some implications from murine foetal and erythroleukemic cells. Rifkind RA; Marks PA; Bank A; Terada M; Maniatis GM; Reuben R; Fibach E Ann Immunol (Paris); 1976; 127(6):887-93. PubMed ID: 1070288 [TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of the erythropoietin receptor gene correlates with erythroid differentiation in rat hematopoietic and leukemic cells. Fujita M; Takahashi R; Kitada K; Watanabe R; Kitazawa S; Ashoori F; Liang P; Saya H; Serikawa T; Maeda S Cancer Lett; 1997 Jan; 112(1):47-55. PubMed ID: 9029168 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin, and development of the erythrocyte membrane. Koury MJ; Bondurant MC; Atkinson JB Blood Cells; 1987; 13(1-2):217-26. PubMed ID: 3478108 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946 [TBL] [Abstract][Full Text] [Related]
11. Changes in G protein pattern and in G protein-dependent signaling during erythropoietin- and dimethylsulfoxide-induced differentiation of murine erythroleukemia cells. Kesselring F; Spicher K; Porzig H Blood; 1994 Dec; 84(12):4088-98. PubMed ID: 7994027 [TBL] [Abstract][Full Text] [Related]
12. Morphological changes in erythroblasts during erythropoietin-induced terminal differentiation in vitro. Koury ST; Koury MJ; Bondurant MC Exp Hematol; 1988 Oct; 16(9):758-63. PubMed ID: 3169158 [TBL] [Abstract][Full Text] [Related]
13. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole. Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412 [TBL] [Abstract][Full Text] [Related]
14. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response. Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239 [TBL] [Abstract][Full Text] [Related]
16. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia. Marks PA; Murate T; Kaneda T; Ravetch J; Rifkind RA Symp Fundam Cancer Res; 1984; 37():327-40. PubMed ID: 6084863 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin activates the receptor in both Rauscher and Friend murine erythroleukemia cells. Chern Y; Spangler R; Choi HS; Sytkowski AJ J Biol Chem; 1991 Feb; 266(4):2009-12. PubMed ID: 1846607 [TBL] [Abstract][Full Text] [Related]
18. RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes. Hensold JO; Barth D; Stratton CA J Cell Physiol; 1996 Jul; 168(1):105-13. PubMed ID: 8647904 [TBL] [Abstract][Full Text] [Related]
19. Procaine inhibits the erythroid differentiation of MEL cells by blocking commitment: possible involvement of calcium metabolism. Tsiftsoglou AS; Mitrani AA; Housman DE J Cell Physiol; 1981 Sep; 108(3):327-35. PubMed ID: 6793604 [TBL] [Abstract][Full Text] [Related]
20. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells. Lo SC; Aft R; Mueller GC Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]